Search Results - "Fauty, Scott E."
-
1
Physicochemical properties, form, and formulation selection strategy for a biopharmaceutical classification system class II preclinical drug candidate
Published in Journal of pharmaceutical sciences (01-10-2014)“…This work summarizes the pharmaceutical evaluation of a preclinical drug candidate with poor physicochemical properties. Compound 1 is a weakly basic, GPR-119…”
Get more information
Journal Article -
2
Combined Use of Crystalline Sodium Salt and Polymeric Precipitation Inhibitors to Improve Pharmacokinetic Profile of Ibuprofen through Supersaturation
Published in AAPS PharmSciTech (01-10-2014)“…To maximize the pharmacological effect of a pain reliever such as ibuprofen, early onset of action is critical. Unfortunately, the acidic nature of ibuprofen…”
Get full text
Journal Article -
3
Using real-time quantitative TaqMan RT-PCR to evaluate the role of dexamethasone in gene regulation of rat P-glycoproteins mdr1a/1b and cytochrome P450 3A1/2
Published in Journal of pharmaceutical sciences (01-10-2004)“…Cytochromes P450 (CYPs) and p-glycoproteins (Pgps) are believed to play important roles in drug absorption, metabolism, and elimination. Numerous drugs and…”
Get more information
Journal Article -
4
Administration of Fenofibrate Markedly Elevates Fabp3 in Rat Liver and Plasma and Confounds Its Use as a Preclinical Biomarker of Cardiac and Muscle Toxicity
Published in Lipids (01-10-2018)“…Proteins involved in lipid homeostasis are often regulated through the nuclear peroxisome proliferator‐activated receptors (PPAR). PPARα is the target for the…”
Get full text
Journal Article -
5
siRNA-Mediated Knockdown of P450 Oxidoreductase in Rats: A Tool to Reduce Metabolism by CYPs and Increase Exposure of High Clearance Compounds
Published in Pharmaceutical research (01-12-2014)“…ABSTRACT Purpose To develop a tool based on siRNA-mediated knockdown of hepatic P450 oxidoreductase (POR) to decrease the CYP-mediated metabolism of small…”
Get full text
Journal Article